These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37591680)

  • 21. Comparative analysis of the efficacy of angiotensin II receptor blockers for uric acid level change in asymptomatic hyperuricaemia.
    Kim HS; Kim H; Lee SH; Kim JH
    J Clin Pharm Ther; 2020 Dec; 45(6):1264-1270. PubMed ID: 32737930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-Year Cardiovascular Outcomes of Telmisartan in Patients With Hypertension: An Electronic Health Record-Based Cohort Study.
    Yum Y; Kim JH; Joo HJ; Kim YH; Kim EJ
    Am J Hypertens; 2024 May; 37(6):429-437. PubMed ID: 38285627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach.
    Nixon RM; Müller E; Lowy A; Falvey H
    Int J Clin Pract; 2009 May; 63(5):766-75. PubMed ID: 19392925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. InterDILI: interpretable prediction of drug-induced liver injury through permutation feature importance and attention mechanism.
    Lee S; Yoo S
    J Cheminform; 2024 Jan; 16(1):1. PubMed ID: 38173043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum to: Development and Verification of Time-Series Deep Learning for Drug-Induced Liver Injury Detection in Patients Taking Angiotensin II Receptor Blockers: A Multicenter Distributed Research Network Approach.
    Heo S; Yu JY; Kang EA; Shin H; Ryu K; Kim C; Chega Y; Jung H; Lee S; Park RW; Kim K; Hwangbo Y; Lee JH; Park YR
    Healthc Inform Res; 2024 Apr; 30(2):168. PubMed ID: 38755108
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term mortality and cardiovascular events of seven angiotensin receptor blockers in hypertensive patients: Analysis of a national real-world database: A retrospective cohort study.
    Lee W; Kang J; Park JB; Seo WW; Lee SY; Lim WH; Jeon KH; Hwang IC; Kim HL
    Health Sci Rep; 2023 Feb; 6(2):e1056. PubMed ID: 36741853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a novel model to predict liver-related mortality in patients with idiosyncratic drug-induced liver injury.
    Wang Y; Zou CL; Zhang J; Qiu LX; Huang YF; Zhao XY; Zou ZS; Jia JD
    Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):584-593. PubMed ID: 37308361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
    J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interpretable machine learning in predicting drug-induced liver injury among tuberculosis patients: model development and validation study.
    Xiao Y; Chen Y; Huang R; Jiang F; Zhou J; Yang T
    BMC Med Res Methodol; 2024 Apr; 24(1):92. PubMed ID: 38643122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examining the association of olmesartan and other angiotensin receptor blockers with overall and cause-specific mortality.
    Lin JW; Chang CH; Caffrey JL; Wu LC; Lai MS
    Hypertension; 2014 May; 63(5):968-76. PubMed ID: 24516110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood pressure outcomes in patients receiving angiotensin II receptor blockers in primary care: a comparative effectiveness analysis from electronic medical record data.
    Ram CV; Ramaswamy K; Qian C; Biskupiak J; Ryan A; Quah R; Russo PA
    J Clin Hypertens (Greenwich); 2011 Nov; 13(11):801-12. PubMed ID: 22051424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization - results from IQVIA™ Disease Analyzer Germany.
    Hedenmalm K; Quinten C; Kurz X; Bradley M; Lee H; Eworuke E
    Eur J Clin Pharmacol; 2023 Jun; 79(6):849-858. PubMed ID: 37095262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoplasm Reports in Food and Drug Administration Adverse Event Reporting System Following Angiotensin Receptor Blocker Recalls.
    Cohen Sedgh R; Moon J; Jackevicius CA
    Circ Cardiovasc Qual Outcomes; 2021 Aug; 14(8):e007476. PubMed ID: 34380327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure.
    Desai RJ; Ashton CM; Deswal A; Morgan RO; Mehta HB; Chen H; Aparasu RR; Johnson ML
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):233-40. PubMed ID: 21786364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Effectiveness of Angiotensin II Receptor Blockers in Patients With Hypertension in Japan　- Systematic Review and Network Meta-Analysis.
    Nakajima T; Oh A; Saita S; Yoshida T; Ohishi M; Nishigaki N
    Circ Rep; 2020 Sep; 2(10):576-586. PubMed ID: 33693183
    [No Abstract]   [Full Text] [Related]  

  • 36. Economic evaluation of four angiotensin II receptor blockers in the treatment of hypertension.
    Miller LA; Wade R; Dai D; Cziraky MJ; Ramaswamy K; Panjabi S
    Curr Med Res Opin; 2010 Jun; 26(6):1307-20. PubMed ID: 20370377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin Receptor Blocker-Related Sprue-like Enteropathy: Review of Food and Drug Administration Adverse Event Reporting System.
    Meader R; Papasotiriou S; Ahdi H; Dang H; Ehrenpreis ED
    Ann Pharmacother; 2024 May; 58(5):494-500. PubMed ID: 37559251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Memory is preserved in older adults taking AT1 receptor blockers.
    Ho JK; Nation DA;
    Alzheimers Res Ther; 2017 Apr; 9(1):33. PubMed ID: 28446207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans.
    Coltamai L; Maillard M; Simon A; Vogt B; Burnier M
    J Hypertens; 2010 Mar; 28(3):520-6. PubMed ID: 20104189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study.
    Wang MG; Wu SQ; Zhang MM; He JQ
    Front Immunol; 2022; 13():1002126. PubMed ID: 36483548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.